MRI biomarkers identify the differential response of glioblastoma multiforme to anti-angiogenic therapy

VEGF Inhibits Tumor Cell Invasion and Mesenchymal Transition through a MET/VEGFR2 Complex

(2012) Kan V. Lu et al.   CANCER CELL

Imaging Biomarker Dynamics in an Intracranial Murine Glioma Study of Radiation and Antiangiogenic Therapy

(2012) Caroline Chung et al.   INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS

Is apparent diffusion coefficient reliable and accurate for monitoring effects of antiangiogenic treatment in a longitudinal study?

(2012) Ji-Yeon Suh et al.   JOURNAL OF MAGNETIC RESONANCE IMAGING

Apparent diffusion coefficient histogram analysis stratifies progression-free and overall survival in patients with recurrent GBM treated with bevacizumab: a multi-center study

(2012) Whitney B. Pope et al.   JOURNAL OF NEURO-ONCOLOGY

High-Resolution In-Vivo Analysis of Normal Brain Response to Cranial Irradiation

(2012) Kelly Burrell et al.   PLoS One

Acquired resistance to drugs targeting receptor tyrosine kinases

(2011) Steven A. Rosenzweig   BIOCHEMICAL PHARMACOLOGY

Anti-angiogenic therapy in glioma

(2011) Nicholas Butowski   Clinical & Translational Oncology

Advances in MRI Assessment of Gliomas and Response to Anti-VEGF Therapy

(2011) Whitney B. Pope et al.   Current Neurology and Neuroscience Reports

Phase II Study of Aflibercept in Recurrent Malignant Glioma: A North American Brain Tumor Consortium Study

(2011) John F. de Groot et al.   JOURNAL OF CLINICAL ONCOLOGY

Phase I study of sunitinib and irinotecan for patients with recurrent malignant glioma

(2011) David A. Reardon et al.   JOURNAL OF NEURO-ONCOLOGY

A clinical trial of bevacizumab, temozolomide, and radiation for newly diagnosed glioblastoma

(2011) Ashwatha Narayana et al.   JOURNAL OF NEUROSURGERY

Tumor invasion after treatment of glioblastoma with bevacizumab: radiographic and pathologic correlation in humans and mice

(2011) J. F. de Groot et al.   NEURO-ONCOLOGY

Quantitative volumetric analysis of conventional MRI response in recurrent glioblastoma treated with bevacizumab

(2011) B. M. Ellingson et al.   NEURO-ONCOLOGY

Differentiating treatment-induced necrosis from recurrent/progressive brain tumor using nonmodel-based semiquantitative indices derived from dynamic contrast-enhanced T1-weighted MR perfusion

(2011) J. Narang et al.   NEURO-ONCOLOGY

DCE and DW-MRI monitoring of vascular disruption following VEGF-Trap treatment of a rat glioma model

(2011) Benjamin A. Hoff et al.   NMR IN BIOMEDICINE

Improved Intratumoral Oxygenation Through Vascular Normalization Increases Glioma Sensitivity to Ionizing Radiation

(2010) Mackenzie C. McGee et al.   INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS

Phase II study of sunitinib malate in patients with recurrent high-grade glioma

(2010) B. Neyns et al.   JOURNAL OF NEURO-ONCOLOGY

Assessment of perfusion MRI-derived parameters in evaluating and predicting response to antiangiogenic therapy in patients with newly diagnosed glioblastoma

(2010) E. Essock-Burns et al.   NEURO-ONCOLOGY

Assessment of multiparametric MRI in a human glioma model to monitor cytotoxic and anti-angiogenic drug effects

(2010) Benjamin Lemasson et al.   NMR IN BIOMEDICINE

Change in diffusion weighted MRI during liver cancer radiotherapy: Preliminary observations

(2009) Cynthia L. Eccles et al.   ACTA ONCOLOGICA

Temporal and dose dependence of T2 and ADC at 9.4 T in a mouse model following single fraction radiation therapy

(2009) Matthew P. Larocque et al.   MEDICAL PHYSICS

piggyBac transposition reprograms fibroblasts to induced pluripotent stem cells

(2009) Knut Woltjen et al.   NATURE

Angiogenesis and Anti-Angiogenic Molecularly Targeted Therapies in Malignant Gliomas

(2009) Andreas A. Argyriou et al.   ONCOLOGY

VEGF Trap induces antiglioma effect at different stages of disease

(2008) Candelaria Gomez-Manzano et al.   NEURO-ONCOLOGY

Malignant Gliomas in Adults

(2008) Patrick Y. Wen et al.   NEW ENGLAND JOURNAL OF MEDICINE